RE:It's all about treatment chargesFire, with release of Q3 it proved you all wrong and yet keep keep coming here while you own no shares cause as you said I can't afford to invest at this time in my life but you do love coming to the board even after getting kicked in the teeth to keep shooting your mouth off. Get a life A H O L E!
firecracker74 wrote: Trevali will be paying about $65M more in treatment charges in 2019 than it did in 2018. This will mean the difference between a $30M profit and a $30M loss. The smelters have a chokehold on Trevali and removing that chokehold is their only hope. TV has been paying down debt in 2019 by taking cash and receivables that were already there and paying off debt. Overall, TV is about $20M cash flow negative for 2019. They would have been $40M cash flow positive with the higher TCs. TV does not have thje cash and receivables to keep paying down debt in 2020. Zinc averaged about $1.15 in 2019 and TV was cash flow negative. There is only so much room to reduce mining costs. AISC was down in quarter 3 because TV is spending a lot less on CAPEX than projected. Reality is that TV will likely be cash flow negative in 2020 if TCs don't come down. Unless zinc prices rally December will be a very difficult month for TV. There will be tax selling and potential fund selling because funds do not like to show that they own a stock that is down 80% on their year end statement. I still think TV may hit .15 by year end. There is only so much TV can control. They cannot control the zinc price and they cannot control the treatment charges. They are in decent shape financially and have plenty of borrowing power. They are not going out of business unless zinc goes under $1 and stays there for a long time. I remain short term negative and long term positive on Trevali. If I were still in the market I would consider loading the boat the last week of December at .15. I will expect the usual personal attacks because I only speak facts and not what people want to hear. For those open to high risk the upside here is incredible IF zinc goes up, treatment charges go down and AISC comes down. $1.25 zinc, lower TCs and .90 AISC makes this a $1 stock in 2021.